How effective is Mobic for Ankylosing Spondylitis? (a real world drug study)
Summary:
Overall ratings: 3/5 Long term ratings: 3.4/5
This is a phase IV clinical study of how effective Mobic (meloxicam) is for Ankylosing spondylitis and for what kind of people. The study is created by eHealthMe from 14 Mobic users and is updated continuously.
What is Mobic?
Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.
What is Ankylosing spondylitis?
Ankylosing spondylitis (type of arthritis affecting the spine) is found to be associated with 748 drugs and 1,048 conditions by eHealthMe. Check the latest studies of Ankylosing spondylitis.
14 people are studied for taking Mobic in Ankylosing spondylitis
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Mobic effectiveness for Ankylosing spondylitis (number of people):
Overall:
- not at all: 1
- somewhat: 3
- moderate: 6
- high: 3
- very high: 1
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 4
- high: 0
- very high: 1
Gender of people who take Mobic for Ankylosing spondylitis *:
- female: 50 %
- male: 50 %
Age of people who take Mobic for Ankylosing spondylitis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 14.29 %
- 20-29: 21.43 %
- 30-39: 7.14 %
- 40-49: 35.71 %
- 50-59: 21.43 %
- 60+: 0.0 %
Who find Mobic more effective for Ankylosing Spondylitis?
Gender of people who take Mobic for Ankylosing spondylitis *:
- female: 75 %
- male: 25 %
Age of people who take Mobic for Ankylosing spondylitis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 25 %
- 20-29: 0.0 %
- 30-39: 25 %
- 40-49: 25 %
- 50-59: 25 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Mobic?
- You can start a phase IV clinical trial to monitor Mobic safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Hung YM, Cheng CC, Wann SR, Lin SL, "Ankylosing spondylitis associated with pulmonary arterial hypertension", Internal Medicine, 2016 Jan .
- Hung YM, Cheng CC, Wann SR, Lin SL, "Ankylosing spondylitis associated with pulmonary arterial hypertension", Internal Medicine, 2016 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Mobic (26,684 reports)
Treatments, associated drugs and conditions:
- Ankylosing spondylitis (130,235 reports)
How the study uses the data?
The study is based on meloxicam (the active ingredients of Mobic) and Mobic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Arixtra and Metoclopramide Hydrochloride - now
- Drug interactions of Depakene and Cipro - 2 seconds ago
- Could Centrum cause Nephritis - Interstitial? - 4 seconds ago
- Could Centrum cause Interstitial Nephritis? - 4 seconds ago
- Could Warfarin Sodium cause Ards (Acute Respiratory Distress Syndrome)? - 11 seconds ago
- Could Centrum Silver cause Ear Discomfort? - 21 seconds ago
- Could Retin-A cause Nausea? - 27 seconds ago
- Could Pletal cause Blister? - 29 seconds ago
- Drug interactions of Propofol and Clonidine Hydrochloride - 32 seconds ago
- Could Micardis cause Chronic Kidney Disease? - 38 seconds ago